Shanghai Shyndec Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001JG2
CNY
9.61
-0.03 (-0.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
2,064.31
2,442.68
2,042.72
2,270.90
2,581.34
2,344.20
2,633.23
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,064.31
2,442.68
2,042.72
2,270.90
2,581.34
2,344.20
2,633.23
Raw Material Cost
1,440.92
1,747.49
1,533.15
1,516.89
1,676.42
1,503.24
1,625.54
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.54
0.22
1.32
1.44
1.41
9.05
9.14
Selling and Distribution Expenses
287.28
383.25
239.60
236.63
336.54
384.49
407.62
Other Expenses
7.83
10.19
9.28
10.89
10.09
13.83
15.01
Total Expenditure (Excl Depreciation)
1,807.02
2,232.85
1,866.83
1,863.82
2,115.23
2,035.12
2,192.44
Operating Profit (PBDIT) excl Other Income
257.3
209.8
175.9
407.1
466.1
309.1
440.79999999999995
Other Income
17.25
109.70
48.59
46.95
56.66
22.92
44.74
Operating Profit (PBDIT)
238.34
392.89
367.70
585.09
679.46
412.29
573.35
Interest
0.54
0.22
1.32
1.44
1.41
9.05
9.14
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
623.39
695.19
509.57
754.01
904.92
840.97
1,007.69
Depreciation
0.00
182.88
182.88
175.90
175.90
194.64
194.64
Profit Before Tax
237.80
209.79
183.50
407.75
502.15
208.59
369.57
Tax
56.18
3.16
27.51
67.24
87.51
83.73
57.73
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
138.40
140.43
129.10
310.65
361.41
129.10
236.05
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
138.40
140.43
129.10
310.65
361.41
129.10
236.05
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
53.74
68.51
33.94
35.99
62.13
3.54
76.51
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
192.14
208.94
163.05
346.64
423.54
132.63
312.56
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
13,917.24
13,778.84
13,638.32
13,643.33
13,565.34
13,203.92
13,074.54
Earnings per share (EPS)
0.1
0.1
0.1
0.23
0.27
0.1
0.18
Diluted Earnings per share
0.1
0.1
0.1
0.23
0.27
0.1
0.18
Operating Profit Margin (Excl OI)
10.71%
4.11%
6.67%
15.95%
17.31%
8.31%
12.68%
Gross Profit Margin
11.52%
16.08%
17.94%
25.7%
26.27%
17.2%
21.43%
PAT Margin
6.7%
5.75%
6.32%
13.68%
14.0%
5.51%
8.96%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -15.49% vs 19.58% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -8.04% vs 28.16% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -21.93% vs -11.25% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 150.00% vs -84.62% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Shanghai Shyndec Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,064.31
0
2,064.31
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,064.31
0
2,064.31
Raw Material Cost
1,440.92
0
1,440.92
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.54
0
0.54
Selling and Distribution Expenses
287.28
0
287.28
Other Expenses
7.83
0.00
7.83
Total Expenditure (Excl Depreciation)
1,807.02
0
1,807.02
Operating Profit (PBDIT) excl Other Income
257.29
0.00
257.29
Other Income
17.25
0
17.25
Operating Profit (PBDIT)
238.34
0
238.34
Interest
0.54
0
0.54
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
623.39
0
623.39
Depreciation
0.00
0
0.00
Profit Before Tax
237.80
0
237.80
Tax
56.18
0
56.18
Provisions and contingencies
0
0
0.00
Profit After Tax
138.40
0
138.40
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
138.40
0
138.40
Share in Profit of Associates
0
0
0.00
Minority Interest
53.74
0
53.74
Other related items
0.00
0.00
0.00
Consolidated Net Profit
192.14
0
192.14
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
13,917.24
0
13,917.24
Earnings per share (EPS)
0.10
0
0.10
Diluted Earnings per share
0.10
0
0.10
Operating Profit Margin (Excl OI)
10.71%
0%
0.00
10.71%
Gross Profit Margin
11.52%
0%
0.00
11.52%
PAT Margin
6.70%
0%
0.00
6.70%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 206.43 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -15.49% vs 19.58% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -20.03% vs -17.36% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 19.21 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -8.04% vs 28.16% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -54.64% vs -0.56% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.11 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -21.93% vs -11.25% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -64.50% vs -6.25% in Mar 2025

Quarterly - Interest
Interest 0.05 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 150.00% vs -84.62% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -64.29% vs -85.26% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.71%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025